EPAS1 and neoplasm: In brief, HIF-1α promotes metabolic reprogramming in tumor cells and TME cells, while HIF-2α induces an aggressive stem-like phenotype within tumor cells, and both contribute to angiogenesis and the production of tumor-licensed TME.